Compare MMT & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMT | OSUR |
|---|---|---|
| Founded | 1987 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.4M | 275.4M |
| IPO Year | N/A | 2000 |
| Metric | MMT | OSUR |
|---|---|---|
| Price | $4.43 | $4.43 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 154.7K | ★ 740.6K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 8.58% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | $14.73 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.37 | $2.08 |
| 52 Week High | $4.87 | $4.58 |
| Indicator | MMT | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 64.92 |
| Support Level | $4.39 | $2.84 |
| Resistance Level | $4.58 | $4.58 |
| Average True Range (ATR) | 0.06 | 0.21 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 12.50 | 76.72 |
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, automotive, chemicals, electronics, and others.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.